Accounting and Governance Risk

 More information
Accounting and Governance Risk (AGR®) is a statistically modeled assessment of corporate integrity which can be used as a confidence level indicator in the company's management and reported financials. Log in for AGR® details.
Close

About Accounting and Governance Risk

The Accounting and Governance Risk (AGR®) Rating & Score is provided by an independent risk research firm, GMI. AGR is widely recognized as a confidence level indicator in the company's management and reported financials.

Scores range from 0 to 100, which correspond to a risk classification for each company ranging from "Very Aggressive" to "Conservative". This percentile ranking represents the stock's AGR Score ranking among the approximately 8,000 companies rated by Audit Integrity. The Industry Percentile is the stock's AGR Score ranking among the companies in the stock's industry. Through continued backtesting, GMI has demonstrated a strong correlation between its quarterly AGR Score and the likelihood of adverse events, including securities class action litigation, financial restatements, regulatory enforcement actions and stock price declines. The AGR Score can help investors to manage risk or enhance investment performance.

  KRO Chemicals Average Industry Percentile
Market Cap $1.86B $12.75B
67th
P/E (Trailing Twelve Months) NM 18.95
13rd
P/E (5-Year Average) 14.83 21.45
29th
PEG Ratio (5-Year Projected) 0.74 1.74
10th
Enterprise Value $1.99B $45.41B
67th
Price/Cash Flow (Most Recent Quarter) 29.98 13.54
92nd
Price/Cash Flow (TTM) -35.89 12.71
6th
Price/Sales (Most Recent Quarter) 1.26 2.06
42nd
Price/Sales (TTM) 1.07 2.07
37th
Price/Book 1.97 3.75
45th

Growth

  KRO Chemicals Average Industry Percentile
EPS Growth (Last Qrtr vs. Same Qrtr Prior Year) -- +14.64%
--
EPS Growth (TTM vs. Prior TTM) -146.28% +65.62%
8th
EPS Growth (Last 5 Years) +57.78% +9.41%
96th
Projected EPS Growth (Next Year vs. This Year) +60.29% +17.09%
94th
Forward EPS Long Term Growth (3-5 Yrs) -24.90% +10.45%
2nd
Revenue % Change (Last Qrtr vs. Same Qrtr Prior Year) -7.11% +7.77%
27th
Revenue % Change (TTM) -12.34% +4.11%
12nd
Revenue Growth (Last 5 Years) +5.64% +2.79%
64th
Capital Spending Growth (Last 5 Years) -0.15% +7.04%
32nd
Book Value per Share Growth (Last 5 Years) +19.99% +6.66%
85th
Cash Flow Growth Rate (Last 5 Years) -2.99% +8.25%
22nd
Cash and Cash Equivalents Increase/Decrease (TTM vs. Prior TTM) $-0.09 $-0.10
40th
Cash and Cash Equivalents Increase/Decrease (Last Qtr vs Prior Qtr.) $-4.06 $-0.20
9th

Profit Margins

  KRO Chemicals Average Industry Percentile
Gross Margin (Most Recent Quarter, Annualized) 17.39% 36.32%
23rd
Gross Margin (TTM) 9.37% 34.75%
10th
EBITD Margin (TTM) -2.41% 18.73%
23rd
Profit Margin (Most Recent Quarter, Annualized) 0.79% 9.17%
35th
Operating Margin (Most Recent Quarter, Annualized) 0.52% 14.38%
29th
Operating Margin (TTM) -5.30% 13.36%
24th
Pretax Margin (Most Recent Quarter, Annualized) -1.00% 12.80%
28th
Pretax Margin (TTM) -9.23% 12.32%
22nd

Returns

  KRO Chemicals Average Industry Percentile
Return on Sales (Most Recent Quarter, Annualized) 0.79% 9.17%
35th
Return on Sales (TTM) -5.89% 8.31%
24th
Return on Equity (Most Recent Quarter, Annualized) 1.24% 21.76%
40th
Return on Equity (TTM) -10.81% 21.08%
25th
Return on Assets (Most Recent Quarter, Annualized) 0.72% 7.21%
47th
Return on Assets (TTM) -5.92% 8.18%
32nd
Return on Investment (Most Recent Quarter, Annualized) 1.02% 13.45%
41st
Return on Investment (TTM) -8.34% 12.58%
25th

Debts

  KRO Chemicals Average Industry Percentile
Long Term Debt/Equity (Most Recent Quarter, Annualized) 19.29% 53.92%
25th
Long Term Debt/Equity (TTM) 25.14% 58.40%
30th
Total Debt/Assets (Most Recent Quarter, Annualized) 11.33% 25.47%
28th
Total Debt/Assets (TTM) 14.72% 26.33%
32nd
Total Debt/Capital (Most Recent Quarter, Annualized) 16.12% --
21st
Total Debt/Capital (TTM) 16.12% 34.70%
21st
Total Debt/Equity (Most Recent Quarter, Annualized) 19.62% 62.82%
24th
Total Debt/Equity (TTM) 26.89% 68.20%
33rd
Current Ratio (TTM) 3.02 2.04
71st
Payout Ratio (TTM) -68.18% 46.30%
5th

Operating Metrics

  KRO Chemicals Average Industry Percentile
Income/Employee (TTM) $-41,632.65 $99,322.05
--
Revenue/Employee (TTM) $707,100.00 $892,280.00
67th
Assets Turnover (Most Recent Quarter, Annualized) 0.91x 0.91x
57th
Assets Turnover (TTM) 1.00x 0.90x
60th
Inventory Turnover (Most Recent Quarter, Annualized) 2.92x --
21st
Inventory Turnover (TTM) 3.51x 5.64x
26th
Receivables Turnover (Most Recent Quarter, Annualized) 5.22x 7.13x
21st
Receivables Turnover (TTM) 5.07x 6.87x
21st
prospectus imageprospectus image S&P Capital IQ® Company Report Secure. Log in required. S&P Capital IQ® - 04/23/14

This generated report* has historical data on financials with interactive charts, technical indicators, and five-year peer comparison trend charts.

*Generated reports are built dynamically when you select them. Reports may not be available for some symbols. Select the link to check availability for this symbol.
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.